Induced pluripotent stem cells in hematology: Current and future applications

D. Focosi, G. Amabile, A. Di Ruscio, P. Quaranta, D. G. Tenen, M. Pistello

Research output: Contribution to journalReview articlepeer-review

Abstract

Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.

Original languageEnglish
Article number211
JournalBlood Cancer Journal
Volume4
Issue number5
DOIs
Publication statusPublished - May 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Induced pluripotent stem cells in hematology: Current and future applications'. Together they form a unique fingerprint.

Cite this